Pharmaceutical benefits in Australia and Sweden: Welfare policy and the cost of prescription drugs

Australian Journal of Social Issues

Volumn 36, Issue 3, 2001, Pages 207-220

  Löfgren, Hans ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0345820280     PISSN: 01576321     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1839-4655.2001.tb01099.x     Document Type: Article

References (19)

1. APMA (2001) Meeting Background Paper http://abc.net.au/4corners/payingtheprice/ apmameeting1.htm (accessed February 2001).
2. Australian Senate (2001) Community Affairs Committee Estimates Committee Transcripts 29 May http://www.aph.gov.au/index.htm (accessed May 2001).
3. Australian National Audit Office (1998) The Pharmaceutical Benefits Scheme, Audit Report 12 1997-98, Canberra, AGPS.
4. Birnbauer, B. & Gray, D. (2001) 'Raiding the medicine cabinet', The Age, May 4, p. 13.
5. Clear, P. (1998) 'Solutions to Current PBS Problems'. Address to 'Private Healthcare & Insurance' Conference, Gazebo Hotel, Sydney, 25 May.
6. Clear, P. (1999) 'The PBS and its Future in the Healthcare Revolution'. Address to the Health Congress '99, Sydney, 24 February.
7. Davies, J.-A. (2001) 'Drug listing costs taxpayers millions', The Age, 2 February, pp. 1, 4.
8. Department of Health and Aged Care (2001) Pharmaceutical Benefits Branch Home Page, http://www.health.gov.au/haf/branch/pbb/index.htm (accessed May 2001).
9. Henry, D.A. & Birkett, D.J. (2001) 'Changes to the Pharmaceutical Benefits Advisory Committee [editorial]', Medical Journal of Australia, 174: 209-10.
10. Hunter, T. (1963) 'Some thoughts on the Pharmaceutical Benefits Scheme', Australian Journal of Social Issues, 1 (4), 32-40.
11. Löfgren, H. (1997) 'Industry policy to set the market free: Drug pricing and the Factor (f) Program', Labour & Industry, 8 (2), 67-84.
12. Olsson, S. E. (1993) Social Policy and Welfare State in Sweden, Lund, Arkiv Förlag.
13. Pharmaceutical Research and Manufacturers of America (2001) PhRMA Special 301 Submission Priority Foreign Countries http://www.phrma.org/intnatl/news/ 2001-02-20.40.pdf (accessed June 2001).
14. Rothstein, B. (1998) Just Institutions Matter: The Moral and Political Logic of the Universal Welfare State, Cambridge, Cambridge University Press.
15. Schweitzer, S. O. (1997) Pharmaceutical Economics and Policy, New York, Oxford University Press.
16. Sloan, C. (1995) A History of the Pharmaceutical Benefits Scheme 1947-1992, Canberra, Commonwealth Department of Human Services and Health.
17. SOU (1998:28) Läkemedel i Vård och Handel: Betänkande av Läkemedelsdistributionsutredningen, Stockholm, Allmänna Förlaget.
18. SOU (1998:50) De 39 Stegen - Läkemedelsutredningar under 1900-talet och Annat Underlagsmaterial till Läkemedel i Vård och Handel: Betänkande av Läkemedelsdistributionsutredningen, Stockholm, Allmänna Förlaget.
19. SOU (2000:86) Den Nya Läkemedelsförmånen, Stockholm, Allmänna Förlaget.